Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy. - Wikidata - wikimedia - TriplyDB

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

http://www.wikidata.org/entity/Q33641986

about

Hyperglycaemia exacerbates choroidal neovascularisation in mice via the oxidative stress-induced activation of STAT3 signalling in RPE cells Diabetic retinopathy: current management and experimental therapeutic targets.Vascular dysfunction in retinopathy-an emerging role for arginase HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.Roles of Nicotinamide Adenine Dinucleotide Phosphate (NADPH) Oxidase in Angiogenesis: Isoform-Specific Effects NOX2-Induced Activation of Arginase and Diabetes-Induced Retinal Endothelial Cell Senescence.Oxidative stress promotes ocular neovascularization.NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy.Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras.Improvement of retinal vascular injury in diabetic rats by statins is associated with the inhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator-activated receptor gamma coactivator 1alpha 12/15-Lipoxygenase-derived lipid metabolites induce retinal endothelial cell barrier dysfunction: contribution of NADPH oxidase Arginase in retinopathy.Targeting Neovascularization in Ischemic Retinopathy: Recent Advances Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury.A lipidomic screen of hyperglycemia-treated HRECs links 12/15-Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase.Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34+ cells.Neuroprotection from retinal ischemia/reperfusion injury by NOX2 NADPH oxidase deletion Adrenergic and serotonin receptors affect retinal superoxide generation in diabetic mice: relationship to capillary degeneration and permeability.The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing.High concentrations of AGE-LDL and oxidized LDL in circulating immune complexes are associated with progression of retinopathy in type 1 diabetes.Downregulating p22phox ameliorates inflammatory response in Angiotensin II-induced oxidative stress by regulating MAPK and NF-κB pathways in ARPE-19 cells Prediction of diabetic retinopathy: role of oxidative stress and relevance of apoptotic biomarkers.Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2.Role of NADPH oxidase in retinal vascular inflammation.Translocation of H-Ras and its implications in the development of diabetic retinopathy.Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity.Diverse effects of statins on angiogenesis: new therapeutic avenues.Inhibition of Stat3 by a Small Molecule Inhibitor Slows Vision Loss in a Rat Model of Diabetic Retinopathy.Anti-inflammatory therapy for diabetic retinopathy.Inflammation in diabetic retinopathy.Inflammation and diabetic retinal microvascular complications.Consequences of oxidative stress in age-related macular degeneration.Oxidative stress, Nox isoforms and complications of diabetes--potential targets for novel therapies.Inflammation and pharmacological treatment in diabetic retinopathy.Molecular mechanisms of diabetic retinopathy: potential therapeutic targets.Statins for prevention of diabetic-related blindness: a new treatment option?Endothelial STAT3 Activation Increases Vascular Leakage Through Downregulating Tight Junction Proteins: Implications for Diabetic Retinopathy.Therapeutic potential of NADPH oxidase 1/4 inhibitors.

P2860

Q28484492-D7C4D111-5629-4586-8B6F-030EF3178833 Q33403016-4E303BC9-0488-4333-8DDE-E19544A09B2C Q33625727-4E7AFF44-3E60-4CBB-8942-05A634B32AFB Q33641974-A5733EF5-4BDC-45BA-B34D-85E106512652 Q33845071-1E40B76E-726C-4956-BAA8-F88764073A0E Q33845094-E9574A3A-0743-4BA5-8142-F40DE7FD6FD9 Q34000654-A8BB79B7-9442-40A8-82A5-B09FFC77A89C Q34003012-A854ABDD-A5D9-472E-83B6-549ACC1254FC Q34022639-9615FDAB-193D-4325-B3E3-C9A813CC0BCE Q34082901-0C897D6C-4D59-4E6D-BF8B-43B6240B039E Q34600290-62164B4E-BD75-41DD-9733-F4FF239D583C Q34800913-4405FFC8-A060-47FF-B867-FAFDDCAE5CBE Q34972210-37CB2448-0F34-401E-BC1C-034B19BCD267 Q35073329-02632D26-4FB2-42DA-9ADA-35BD73722D43 Q35120919-071FD7CA-EED3-4E2A-9FDD-358E05F280A5 Q35221390-772C1BD7-0375-49C3-9BFA-684F6E3C74B2 Q35522186-5AEEBC69-9DE4-4609-9761-3E7A4227EC44 Q35555144-3B31941D-9DCB-4D5A-85C5-80B5A913F07F Q35591658-2F729BA7-6611-4385-82B4-2C3314ABBBF2 Q35947546-91F02F32-43B0-4E1A-A5B1-D0AB2E85C80A Q35976427-9309A518-BB46-486F-BB47-A2AD1A95E919 Q36101886-EA69CC2E-49E6-41BF-B8AD-37B5CD559D14 Q36117585-0EF07770-D738-4D42-9225-5AB7EADD332E Q36271043-BEAEA687-4B6E-4609-AF77-75377C012EE8 Q37195371-11B0850D-3A7C-4174-8487-A0EFD5A03292 Q37233106-FCAE988C-F113-4CF8-85E9-8E8054667B06 Q37349070-B6ED9264-567D-417C-A3FE-9C17E4458AF5 Q37623450-784B34AF-678B-4FA6-AD27-D9CDF84B30B2 Q37680944-A922399B-992D-4F85-A7AB-9F9C9A1A03DF Q37744827-9F3066D8-2517-42A7-84BE-FA935AF0E8B5 Q37873482-AE2F3CE9-9E3A-484E-A35F-F89C83E11F35 Q37884176-731343A0-6A47-4B70-AAB9-968EBD886E4C Q37911285-20F75D28-83C8-4FE1-A5B6-97A49CDDF49B Q38003229-99F5E84E-0707-49AE-B8A2-0EE7C74C62BD Q38019841-F92DEA0D-2591-438E-9ADB-6033E83B32DB Q38167309-87D7A5A7-19BD-46D7-9BC4-691631A6879C Q38463463-EC3021A0-3EBF-4DE4-9E9B-411837C9A9B2 Q38506903-E025E736-832C-4F53-8788-A7D0AA8D1199 Q38748869-63820C73-A719-4AD9-A063-67B9AE704E8E Q38858553-BCB36CBE-FD60-4328-B3CD-62A7E997A79E

P2860

Role of NADPH oxidase and Stat3 in statin-mediated protection against diabetic retinopathy.

http://www.wikidata.org/entity/Q33641986

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Role of NADPH oxidase and Stat ...... against diabetic retinopathy.

@ast

Role of NADPH oxidase and Stat ...... against diabetic retinopathy.

@en

type

label

Role of NADPH oxidase and Stat ...... against diabetic retinopathy.

@ast

Role of NADPH oxidase and Stat ...... against diabetic retinopathy.

@en

prefLabel

Role of NADPH oxidase and Stat ...... against diabetic retinopathy.

@ast

Role of NADPH oxidase and Stat ...... against diabetic retinopathy.

@en

P1433

Q33641986-BE9CBC8E-BD57-44A2-90AA-3607246BD8D1

P1476

Q33641986-17F25B52-FF81-4626-B0C6-C89C70873E0B

P2093

Q33641986-19AB7E6B-1A1C-45E7-BDE4-71CD34B310FE

Q33641986-80A46E27-B968-4FE8-8B9F-3CAEDEE49256

Q33641986-9B8200AA-04B9-4939-9F2E-B2144837E1FA

Q33641986-AED53DBE-ACA8-46D9-B652-EE06156F9A06

Q33641986-B34B7429-68B8-4663-8881-29C8737ABFBA

Q33641986-BACACDEF-4A5C-4D99-A75E-449E013C2EE4

Q33641986-F9B8E2AB-6967-4C37-9876-536EBE9BFC2F

P2860

Q33641986-0292A78C-7235-41D3-AE46-34B924C555E9

Q33641986-0C21CBC3-938E-408A-BF31-5E5C86FE6020

Q33641986-0F6C400A-9E3D-4B17-9854-D84668A73163

Q33641986-131AB25D-A720-44F9-8D02-8A46CC92BB5A

Q33641986-2D434534-8C85-49C6-B39F-47697D9441C3

Q33641986-320F8392-8B1F-4436-9846-DC7EA0303D5D

Q33641986-34782947-2D9C-48CA-BE09-CA6A0659F4F3

Q33641986-3A77F275-91D1-4E6D-95D6-302BD6D1B5A8

Q33641986-40F7F073-FBC3-4CCA-8DFF-26BFA3B8EFCC

Q33641986-47925EB6-634A-48BC-9047-FDF451C001A3

P304

Q33641986-97DBD361-DC7B-48E4-AA62-286F551871DF

P31

Q33641986-2806EE22-A615-4E66-BA25-2C8774AE97E9

P356

Q33641986-342C7232-6569-4A6F-9E8D-BF19C30E487E

P407

Q33641986-C3517F52-131F-42AB-AF7F-C0976B96D140

P433

Q33641986-201307FA-1288-422D-AC60-C3C8914514E4

P478

Q33641986-075FB99A-C557-4201-83DD-62A45B7632CB

P50

Q33641986-40BCC4C6-ECFD-408E-8302-75D03855E99B

P577

Q33641986-A69543B3-B7CB-4497-9BC7-1439FEC5427E

P5875

Q33641986-A7344C89-1990-494D-8C7B-4A5E1C356E41

P698

Q33641986-FD5B346C-2F25-40F0-80C3-5CEC3F427766

P932

Q33641986-4DA74D34-514F-4AA1-B3A0-66DD27787AC2

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Role of NADPH oxidase and Stat ...... n against diabetic retinopathy

@en

P2093

Azza B El-Remessy

http://www.w3.org/2001/XMLSchema#string

Guochuan Ma

http://www.w3.org/2001/XMLSchema#string

Manuela Bartoli

http://www.w3.org/2001/XMLSchema#string

R William Caldwell

http://www.w3.org/2001/XMLSchema#string

Ruth B Caldwell

http://www.w3.org/2001/XMLSchema#string

Suraporn Matragoon

http://www.w3.org/2001/XMLSchema#string

Tahira Lemtalsi

http://www.w3.org/2001/XMLSchema#string

P2860

Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes

Pleiotropic effects of statins

Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia.

Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.

Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress.

Molecular mechanisms of vascular permeability in diabetic retinopathy.

Serine phosphorylation of STATs.

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells.

P304

3231-3238

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.08-1754

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Mohamed Al-Shabrawey

P577

2008-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5473242

http://www.w3.org/2001/XMLSchema#string

P698

18378570

http://www.w3.org/2001/XMLSchema#string

P932

2819293

http://www.w3.org/2001/XMLSchema#string